183 related articles for article (PubMed ID: 17997080)
1. A triclosan-ciprofloxacin cross-resistant mutant strain of Staphylococcus aureus displays an alteration in the expression of several cell membrane structural and functional genes.
Tkachenko O; Shepard J; Aris VM; Joy A; Bello A; Londono I; Marku J; Soteropoulos P; Peteroy-Kelly MA
Res Microbiol; 2007; 158(8-9):651-8. PubMed ID: 17997080
[TBL] [Abstract][Full Text] [Related]
2. Microarray analysis of toxicogenomic effects of triclosan on Staphylococcus aureus.
Jang HJ; Chang MW; Toghrol F; Bentley WE
Appl Microbiol Biotechnol; 2008 Mar; 78(4):695-707. PubMed ID: 18210102
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
Zhao X; Quinn B; Kerns R; Drlica K
J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
[TBL] [Abstract][Full Text] [Related]
4. Signature gene expression profile of triclosan-resistant Escherichia coli.
Yu BJ; Kim JA; Pan JG
J Antimicrob Chemother; 2010 Jun; 65(6):1171-7. PubMed ID: 20410062
[TBL] [Abstract][Full Text] [Related]
5. Small-colony variants: a novel mechanism for triclosan resistance in methicillin-resistant Staphylococcus aureus.
Seaman PF; Ochs D; Day MJ
J Antimicrob Chemother; 2007 Jan; 59(1):43-50. PubMed ID: 17079243
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic changes in ciprofloxacin-resistant Staphylococcus aureus.
Mesak LR; Davies J
Res Microbiol; 2009 Dec; 160(10):785-91. PubMed ID: 19818400
[TBL] [Abstract][Full Text] [Related]
7. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
Sabatini S; Kaatz GW; Rossolini GM; Brandini D; Fravolini A
J Med Chem; 2008 Jul; 51(14):4321-30. PubMed ID: 18578473
[TBL] [Abstract][Full Text] [Related]
8. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.
Couto I; Costa SS; Viveiros M; Martins M; Amaral L
J Antimicrob Chemother; 2008 Sep; 62(3):504-13. PubMed ID: 18511413
[TBL] [Abstract][Full Text] [Related]
9. Whither triclosan?
Russell AD
J Antimicrob Chemother; 2004 May; 53(5):693-5. PubMed ID: 15073159
[TBL] [Abstract][Full Text] [Related]
10. Mutations upstream of fabI in triclosan resistant Staphylococcus aureus strains are associated with elevated fabI gene expression.
Grandgirard D; Furi L; Ciusa ML; Baldassarri L; Knight DR; Morrissey I; Largiadèr CR; Leib SL; Oggioni MR
BMC Genomics; 2015 Apr; 16(1):345. PubMed ID: 25924916
[TBL] [Abstract][Full Text] [Related]
11. Triclosan resistance in methicillin-resistant Staphylococcus aureus expressed as small colony variants: a novel mode of evasion of susceptibility to antiseptics.
Bayston R; Ashraf W; Smith T
J Antimicrob Chemother; 2007 May; 59(5):848-53. PubMed ID: 17337510
[TBL] [Abstract][Full Text] [Related]
12. A novel resistance mechanism to triclosan that suggests horizontal gene transfer and demonstrates a potential selective pressure for reduced biocide susceptibility in clinical strains of Staphylococcus aureus.
Ciusa ML; Furi L; Knight D; Decorosi F; Fondi M; Raggi C; Coelho JR; Aragones L; Moce L; Visa P; Freitas AT; Baldassarri L; Fani R; Viti C; Orefici G; Martinez JL; Morrissey I; Oggioni MR;
Int J Antimicrob Agents; 2012 Sep; 40(3):210-20. PubMed ID: 22789727
[TBL] [Abstract][Full Text] [Related]
13. Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?
Gilbert P; Allison DG; McBain AJ
Symp Ser Soc Appl Microbiol; 2002; (31):98S-110S. PubMed ID: 12481835
[TBL] [Abstract][Full Text] [Related]
14. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
Rieg S; Huth A; Kalbacher H; Kern WV
Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
[TBL] [Abstract][Full Text] [Related]
15. Effect of triclosan or a phenolic farm disinfectant on the selection of antibiotic-resistant Salmonella enterica.
Randall LP; Cooles SW; Piddock LJ; Woodward MJ
J Antimicrob Chemother; 2004 Sep; 54(3):621-7. PubMed ID: 15269199
[TBL] [Abstract][Full Text] [Related]
16. Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus.
Kumar A; Khan IA; Koul S; Koul JL; Taneja SC; Ali I; Ali F; Sharma S; Mirza ZM; Kumar M; Sangwan PL; Gupta P; Thota N; Qazi GN
J Antimicrob Chemother; 2008 Jun; 61(6):1270-6. PubMed ID: 18334493
[TBL] [Abstract][Full Text] [Related]
17. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of bacterial biocide and antibiotic resistance.
Poole K
Symp Ser Soc Appl Microbiol; 2002; (31):55S-64S. PubMed ID: 12481829
[TBL] [Abstract][Full Text] [Related]
19. Emergence and maintenance of resistance to fluoroquinolones and coumarins in Staphylococcus aureus: predictions from in vitro studies.
Vickers AA; O'Neill AJ; Chopra I
J Antimicrob Chemother; 2007 Aug; 60(2):269-73. PubMed ID: 17556355
[TBL] [Abstract][Full Text] [Related]
20. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium.
Zheng J; Cui S; Meng J
J Antimicrob Chemother; 2009 Jan; 63(1):95-102. PubMed ID: 18984645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
